Inhibition of p38 MAPK Signaling Regulates the Expression of EAAT2 in the Brains of Epileptic Rats

Seizures induce the release of excitatory amino acids (EAAs) from the intracellular fluid to the extracellular fluid, and the released EAAs primarily comprise glutamic acid (Glu) and asparaginic acid (Asp). Glu neurotransmission functions via EAA transporters (EAATs) to maintain low concentrations of Glu in the extracellular space and avoid excitotoxicity. EAAT2, the most abundant Glu transporter subtype in the central nervous system (CNS), plays a key role in the regulation of glutamate transmission. Previous studies have shown that SB203580 promotes EAAT2 expression by inhibiting the p38 mitogen-activated protein kinase (MAPK) signaling pathway, but whether SB203580 upregulates EAAT2 expression in epileptic rats is unknown. This study demonstrated that EAAT2 expression was increased in the brain tissue of epileptic rats. Intraperitoneal injection of a specific inhibitor of p38 MAPK, SB203580, reduced the time to the first epileptic seizure and attenuated the seizure severity. In addition, SB203580 treatment increased the EAAT2 expression levels in the brain tissue of epileptic rats. These results suggest that SB203580 could regulate epileptic seizures via EAAT2.

• Publication year

  2018

• Venue

  Frontiers in Neurology

• Publication date

  2018-10-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fneur.2018.00925PMID 30429824PMCID 6220601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy.

  2016cited by this paper
• Inhibition of p38 mitogen‐activated protein kinase signaling reduces multidrug transporter activity and anti‐epileptic drug resistance in refractory epileptic rats

  2016cited by this paper
• A signal processing based analysis and prediction of seizure onset in patients with epilepsy

  2015cited by this paper
• Current approaches to enhance glutamate transporter function and expression

  2015cited by this paper
• Conditional Deletion of the Glutamate Transporter GLT-1 Reveals That Astrocytic GLT-1 Protects against Fatal Epilepsy While Neuronal GLT-1 Contributes Significantly to Glutamate Uptake into Synaptosomes

  2015cited by this paper
• Epilepsy: new advances.

  2015cited by this paper
• Blockade of endothelin B receptor improves the efficacy of levetiracetam in chronic epileptic rats.

  2015cited by this paper
• Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease

  2015cited by this paper
• δ‐Opioid receptors up‐regulate excitatory amino acid transporters in mouse astrocytes

  2014cited by this paper
• Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection.

  2014cited by this paper
• Translational enhancers of EAAT2: therapeutic implications for neurodegenerative disease.

  2014cited by this paper
• Premature mortality in active convulsive epilepsy in rural Kenya

  2014cited by this paper
• New mechanism for glutamate hypothesis in epilepsy

  2013cited by this paper
• Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus.

  2012cited by this paper
• The Density of EAAC1 (EAAT3) Glutamate Transporters Expressed by Neurons in the Mammalian CNS

  2012cited by this paper
• Glutamate Release by Primary Brain Tumors Induces Epileptic Activity

  2011cited by this paper
• Evidence that compromised K+ spatial buffering contributes to the epileptogenic effect of mutations in the human kir4.1 gene (KCNJ10)

  2011cited by this paper
• Structure-activity relationship study of pyridazine derivatives as glutamate transporter EAAT2 activators.

  2011cited by this paper
• Whole transcriptome analysis of the hippocampus: toward a molecular portrait of epileptogenesis

  2010cited by this paper
• Identification of Translational Activators of Glial Glutamate Transporter EAAT2 through Cell-Based High-Throughput Screening

  2010cited by this paper
• Mechanism of Ceftriaxone Induction of Excitatory Amino Acid Transporter-2 Expression and Glutamate Uptake in Primary Human Astrocytes*

  2008cited by this paper
• Gliogenesis and glial pathology in depression.

  2007cited by this paper
• Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement

  2007cited by this paper
• Translational Control of Glial Glutamate Transporter EAAT2 Expression*

  2007cited by this paper
• β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

  2005cited by this paper
• Extracellular metabolites in the cortex and hippocampus of epileptic patients

  2005cited by this paper
• Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway

  2004influential reference
• Regulation of glial glutamate transporter expression by growth factors.

  2003cited by this paper
• TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes.

  2003cited by this paper
• TNF‐α induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3‐L1 adipocytes

  2003cited by this paper
• Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin‐1

  2002cited by this paper
• Delayed induction of p38 MAPKs in reactive astrocytes in the brain of mice after KA-induced seizure.

  2001cited by this paper
• Epidermal Growth Factor Receptor Agonists Increase Expression of Glutamate Transporter GLT-1 in Astrocytes through Pathways Dependent on Phosphatidylinositol 3-Kinase and Transcription Factor NF-κB

  2000cited by this paper
• Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT-1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB.

  2000cited by this paper
• Inhibition of p38 MAP kinase as a therapeutic strategy.

  2000cited by this paper
• Interactions of excitatory neurotransmitters and xenobiotics in excitotoxicity and oxidative stress: glutamate and lead.

  1998cited by this paper
• Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1.

  1997cited by this paper
• Brain Glutamate Transporter Proteins Form Homomultimers*

  1996cited by this paper
• Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.

  1996cited by this paper
• Glutamate, GABA and epilepsy.

  1995cited by this paper
• Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain.

  1993cited by this paper
• An osmosensing signal transduction pathway in yeast.

  1993cited by this paper
• An [Na+ + K+]coupled L-glutamate transporter purified from rat brain is located in glial cell processes.

  1992cited by this paper

• Advances in acupuncture modulation of signaling pathways for epilepsy treatment: A review

  2025cites this paper
• Docosahexaenoic acid provides a protective effect in amygdala-kindled rats by activating peroxisome proliferator-activated receptor α.

  2025cites this paper
• The role of glutamate receptors and transporters in epilepsy: evidence from animal studies

  2025cites this paper
• Mitochondria-targeting peptide SS-31 attenuates ferroptosis via inhibition of the p38 MAPK signaling pathway in the hippocampus of epileptic rats.

  2024cites this paper
• The role of extracellular glutamate homeostasis dysregulated by astrocyte in epileptic discharges: a model evidence

  2023cites this paper
• Hippocampal tandem mass tag (TMT) proteomics analysis during kindling epileptogenesis in rat.

  2023cites this paper
• Activated protein C in epilepsy pathophysiology

  2023cites this paper
• Bone marrow stromal cells-derived exosomes reduce neurological damage in traumatic brain injury through the miR-124-3p/p38 MAPK/GLT-1 axis.

  2023cites this paper
• Exosomes derived from bone marrow mesenchymal stem cells attenuate neurological damage in traumatic brain injury by alleviating glutamate-mediated excitotoxicity.

  2022cites this paper
• Lactobacillus Plantarum -derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis cross-species

  2022cites this paper
• Protective effects of apigenin on methylmercury-induced behavioral/neurochemical abnormalities and neurotoxicity in rats

  2022cites this paper
• Ibuprofen treatment ameliorates memory deficits in rats with collagen-induced arthritis by normalizing aberrant MAPK/NF-κB and glutamatergic pathways.

  2022cites this paper
• The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders

  2022cites this paper
• Neurotoxicity mechanism of aconitine in HT22 cells studied by microfluidic chip-mass spectrometry

  2022cites this paper
• Lactobacillus Plantarum-derived extracellular vesicles protect against ischemic brain injury via the microRNA-101a-3p/c-Fos/TGF-β axis.

  2022cites this paper
• Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: opportunities for novel therapeutics development.

  2021cites this paper
• Critical amino acids in the TM2 of EAAT2 are essential for membrane‐bound localization, substrate binding, transporter function and anion currents

  2021cites this paper
• Downregulation of CD40L–CD40 attenuates seizure susceptibility and severity of seizures

  2021cites this paper
• Prophylactic Activation of Shh Signaling Attenuates TBI-Induced Seizures in Zebrafish by Modulating Glutamate Excitotoxicity through Eaat2a

  2021cites this paper
• Reviving Mitochondrial Bioenergetics: a relevant approach in epilepsy.

  2021cites this paper
• Myelination during fracture healing in vivo in myelin protein zero (p0) transgenic medaka line.

  2020cites this paper
• Inhibition of p38 MAPK regulates epileptic severity by decreasing expression levels of A1R and ENT1

  2020cites this paper
• Newest Targets for Anticonvulsant Agents: An Overview

  2019cites this paper
• Ferrostatin-1 mitigates cognitive impairment of epileptic rats by inhibiting P38 MAPK activation.

  2019cites this paper
• Uncovering the Pharmacological Mechanism of Chaibei Zhixian Decoction on Epilepsy by Network Pharmacology Analysis

  2019cites this paper
• Losmapimod Protected Epileptic Rats From Hippocampal Neuron Damage Through Inhibition of the MAPK Pathway

  2019cites this paper